Companies / Context Therapeutics Inc. / Activity
Activity — Context Therapeutics Inc.
6 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | SG Americas Securities, LLC 13F manager | New | Common stock | $9 | +15K | 15,462 0.02% of shares | low |
| Q3 2025 as of | Barclays PLC 13F manager | New | Common stock | $162 | +167 | 167 <0.01% of shares | low |
| Q2 2026 as of | Deutsche Bank AG 13F manager | New | Common stock | $50.0K | +91K | 90,882 0.10% of shares | low |
| Q2 2026 as of | Timothy G. Youngquist 2020 Irrevocable Trust 13F manager | New | Common stock | $109.9K | +198K | 198,384 0.22% of shares | low |
| Q1 2026 as of | OMERS Administration Corporation 13F manager | New | Common stock | $211.2K | +81K | 80,600 0.09% of shares | low |
| Q1 2026 as of | Adage Capital Partners Gp, L.L.C. 13F manager | New | Common stock | $2.62M | +1.0M | 1,000,000 1.09% of shares | low |